substitute

(redirected from Blood substitute)
Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • verb
  • noun
  • adj

Synonyms for substitute

Synonyms for substitute

one that takes the place of another

to give up in return for something else

to act as a substitute

Synonyms for substitute

a person or thing that takes or can take the place of another

an athlete who plays only when a starter on the team is replaced

someone who takes the place of another (as when things get dangerous or difficult)

be a substitute

capable of substituting in any of several positions on a team

Synonyms

Related Words

serving or used in place of another

Related Words

artificial and inferior

Synonyms

Related Words

References in periodicals archive ?
The military's desire for blood substitutes focuses on the so-called "golden hour," the crucial first 30 to 60 minutes on the battlefield after injury.
In fact, the human-derived hemoglobin oxygen-carrying component is even purified before being added to the blood substitute solution.
HemoBioTech is engaged in the development of HemoTech, a novel human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center.
Clark's startling experiments inspired other researchers to test related fluorocarbon liquids for their usefulness as blood substitutes.
The Company has under development a blood substitute, a liquid ventilation product and an implantable glucose sensor.
The company noted that while recent reports have suggested that other blood substitute sponsors are experiencing problems in elective surgery trials, Northfield's focus always has been in the trauma, or urgent, acute blood loss market.
located near Seattle, Washington, is a developer of blood substitute and drug delivery products.
Nasdaq: SNUS) announced today that it has implemented a restructuring plan to support its strategic decision to refocus on the development of its drug delivery and blood substitute products, as announced on October 12, 2000.
Oxycyte(TM) is Synthetic Blood's proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
Nasdaq: SNUS) announced today a strategic decision to refocus the Company on the development of its drug delivery and blood substitute products.
Nasdaq: SNUS) announced today the signing of an agreement with The State University of New York at Buffalo (SUNY/UB) to work together in developing blood substitute products for intravascular oxygen delivery.
Gould, violated the federal securities laws when the Company issued a series of materially false and misleading statements concerning the safety and history of the Company's sole product, a blood substitute called PolyHeme.
Additionally, Northfield will describe results of studies in trauma, demonstrating an increase in survival in patients suffering from blood loss who received the company's blood substitute, PolyHeme(TM).
The Complaint alleges the Company issued a series of materially false and misleading statements concerning the safety and history of the Company's sole product, a blood substitute called PolyHeme, which caused Northfield's stock price to become artificially inflated, inflicting damages on investors.
Oxycyte, Synthetic Blood's proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute, is being administered in this Phase II study to increase the solubility of oxygen in the blood and thus improve oxygen delivery to the acutely injured brain following traumatic head injury.